Oral mucositis and outcomes of allogeneic hematopoietic stem-cell transplantation in patients with hematologic malignancies

Supportive Care in Cancer

Volumn 15, Issue 5, 2007, Pages 491-496

  Vera Llonch, Montserrat ^a   Oster, Gerry ^a   Ford, Colleen M ^b   Lu, John ^c   Sonis, Stephen ^b  

^a POLICY ANALYSIS INC PAI   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c AMGEN INC   (United States)

Author keywords

Allogeneic; Costs; Hematopoietic stem cell transplantation; Oral mucositis; Outcomes

Indexed keywords

NARCOTIC AGENT;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; DISEASE SEVERITY; ERYTHEMA; FEMALE; FEVER; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORTALITY; MOUTH ULCER; MUCOSA INFLAMMATION; ORAL MUCOSAL DISEASE; OROPHARYNX; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; TOTAL PARENTERAL NUTRITION; VALIDATION STUDY; WHOLE BODY RADIATION;

ADULT; ANTINEOPLASTIC AGENTS; BOSTON; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MEDICAL AUDIT; MIDDLE AGED; RETROSPECTIVE STUDIES; STOMATITIS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 34147156196     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-006-0176-9     Document Type: Article

References (14)

1. Bellm LA, Epstein JB, Rose-Ped A et al (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33-39
2. Cutler C, Li S, Kim HT et al (2005) Mucositis after allogeneic hematopoietic stem cell transplantation: a cohort study of methotrexate- and non-methotrexate-containing graft-versus-host disease prophylaxis regimens. Biol Blood Marrow Transplant 11(5):383-388
3. Elting LS, Cooksley C, Chambers M et al (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531-1539
4. Hwang WYK, Koh L-P, Ng HJ et al (2004) A randomized trial of amifostine as a cytoprotectant for patients receiving myeloablative therapy for allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 34:51-56
5. McGuire DB, Altomonte V, Peterson DE et al (1993) Patterns of mucositis and pain in patients receiving preparatory and bone marrow transplantation. Oncol Nurs Forum 20:1493-1502
6. Monopoli M, Woo S, Valley M, Sonis S (1991) A site-based scoring system of chemotherapy-induced oral mucositis in bone marrow transplant recipients. Proceedings of the Annual Meeting of the Society for Oral Oncology (abstract)
7. Rapoport AP, Miller Watelet LF, Linder T et al (1999) Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem-cell transplants. J Clin Oncol 17:2446-2453
8. Robien K, Schubert MM, Bruemmer B et al (2004) Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol 22:1268-1275
9. Ruescher TJ, Sodeifi A, Scrivani SJ et al (1998) The impact of mucositis on alpha-hemolytic streptococcal infection in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82(11):2275-2281
10. Sonis ST, Oster G, Fuchs H et al (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19(8):2201-2205
11. Spielberger R, Stiff P, Bensinger W et al (2004) Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 351:2590-2598
12. Wardley AM, Jayson GC, Swindell R et al (2000) Prospective evaluation of oral mucositis in patients receiving myeloablative conditioning regimens and haemopoeitic progenitor rescue. Br J Haematol 110:292-299
13. Woo SB, Sonis ST, Monopoli MM et al (1993) A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer 72:1612-1617
14. Zerbe MB, Parkerson SG, Ortlieb ML et al (1992) Relationships between oral mucositis and treatment variables in bone marrow transplant patients. Cancer Nurs 15:196-205